Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

110

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Is mitochondrial morphology important for cellular physiology?

Is mitochondrial morphology important for cellular phys...

120

Exercise pills for cardiometabolic health cannot mimic the exercise milieu

Exercise pills for cardiometabolic health cannot mimic ...

82

Remodeling synaptic connections via engineered neuron-astrocyte interactions

Remodeling synaptic connections via engineered neuron-a...

63